Cancer center support grant

癌症中心补助金

• 批准号: 10372714
• 负责人: RAPHAEL E. POLLOCK
• 金额: $ 1.08万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-09-12 至 2025-11-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10372714
• 关键词: Address; African American; Appalachian Region; Asians; Awareness; Basic Science; Breast; Cancer Center; Cancer Center Support Grant; Cancer Hospital; Caring; Catchment Area; Caucasians; Clinical Research; Clinical Trials; Colorectal; Communities; Community Health; Community Networks; Community Outreach; Comprehensive Cancer Center; Development; Diagnosis; Education and Outreach; Endometrial; Ensure; Foundations; Goals; Health Educators; Hispanics; Human Papilloma Virus Vaccination; Human Papilloma Virus Vaccine; Human Papillomavirus; Individual; Knowledge; Latino; Lead; Lesbian Gay Bisexual Transgender Queer; Longevity; Low income; Lung; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Mission; Modality; Morbidity - disease rate; Multicultural Education; Obesity; Ohio; Policies; Population; Population Heterogeneity; Population Research; Prostate; Public Health; Recording of previous events; Refugees; Research; Research Institute; Research Personnel; Rural; Scanning; Screening for cancer; Thyroid Gland; Tobacco use; Translational Research; Underserved Population; Universities; University resources; Vaccination; Vision; Work; cancer care; care seeking; clinical trial implementation; community based participatory research; community engagement; disparity elimination; ethnic diversity; ethnic minority population; health disparity; leukemia; minority communities; mortality; outreach; prevent; programs; racial and ethnic; rural counties; screening; underserved community; uptake; urban underserved; vaccine acceptance

Project Summary The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has been a NCI designated CCC since 1976. The OSUCCC mission remains to reduce cancer morbidity and mortality through continued basic, translational, population and clinical research. Eliminating disparities across the continuum of cancer care, with the inclusion of a diverse population in research, is vital to the development of new modalities to prevent, diagnose, and treat cancer. The OSUCCC is committed to providing the best care across the cancer continuum to all individuals who seek care at our facilities, which includes participation in research. One way to ensure that the population within the OSUCC-James catchment area receives best possible care is through engaging the various communities and providing cancer awareness, especially an understanding of the importance of trial participation. We will focus the proposed supplement on implementing a Clinical Trials Initiative within our urban underserved African American, low income Caucasian, Hispanic/Latino, Asian, and refugee (Somali and Nepali) communities, and an HPV Vaccination Initiative in all of these populations, as well as in our Appalachian and rural counties. To accomplish the goals of this NON supplement and build upon previous outreach efforts aimed at eliminating health disparities, OSUCCC will utilize two community health educators (1.2 total FTE) to work in partnership with researchers and key NCI-sponsored academic, and community, and regional partners to enhance NCI’s ability to effectively reach underserved and minority communities through achieving the following specific aims: Aim 1: Increase awareness and knowledge about clinical trials and biospecimen research and facilitate participation in clinical trials among racially/ethnically diverse communities in urban Columbus communities through implementation of Clinical Trial (CT) & Biospecimen Studies Participation Initiative; and Aim 2: Increase awareness and knowledge of the HPV types that can lead to cancer and uptake of the HPV vaccine in the various underserved populations in our catchment area through implementation of the Human Papillomavirus (HPV) Outreach and Vaccination initiative.

项目摘要 俄亥俄州立大学综合癌症中心 - 亚瑟·G·詹姆斯癌症医院和 Richard J. Solove研究所（OSUCCC - James）自1976年以来一直是NCI指定的CCC。 OSUCCC任务仍将通过持续的基础，翻译，降低癌症发病率和死亡率 人口和临床研究。 消除癌症护理连续性的差异，其中包括多样性人群 研究对于预防，诊断和治疗癌症的新方式的发展至关重要。 OSUCCC是 致力于在所有在我们的设施中寻求护理的人继续提供整个癌症的最佳护理， 其中包括参与研究。确保OSUCC-James中的人口 集水区获得最佳护理是通过与各个社区互动并提供癌症 意识，尤其是对试验参与的重要性的理解。 我们将把拟议的补充剂重点放在我们的城市中实施临床试验计划上 服务不足的非裔美国人，低收入高加索人，西班牙裔/拉丁裔，亚洲和难民（索马里和尼泊尔） 社区，以及所有这些人群以及我们的阿巴拉契亚语和 农村县。 实现这种非补充的目标，并以先前的外展努力为基础 消除健康差异，OSUCCC将利用两名社区健康教育者（1.2总FTE）工作 与研究人员和主要NCI赞助的学术，社区以及区域合作伙伴的合作关系 通过实现以下内容，增强了NCI有效达到服务欠缺和少数群体社区的能力 具体目的： 目的1：提高人们对临床试验和生物循环研究的认识和知识，并促进 参与城市哥伦布社区大致/种族多元化社区的临床试验 通过实施临床试验（CT）和生物测量研究参与计划；和 目标2：提高对HPV类型的认识和知识，这些类型可能导致癌症和HPV的吸收 通过实施人类，我们集水区的各种服务不足的种群中的疫苗 乳头瘤病毒（HPV）外展和疫苗接种计划。